In last trading session, Trinity Biotech Plc ADR (NASDAQ:TRIB) saw 0.13 million shares changing hands with its beta currently measuring 0.98. Company’s recent per share price level of $1.12 trading at -$0.01 or -1.33% at ring of the bell on the day assigns it a market valuation of $12.68M. That closing price of TRIB’s stock is at a discount of -216.96% from its 52-week high price of $3.55 and is indicating a premium of 6.25% from its 52-week low price of $1.05. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 76840.0 shares which gives us an average trading volume of 1.29 million if we extend that period to 3-months.
Trinity Biotech Plc ADR (NASDAQ:TRIB) trade information
Upright in the red during last session for losing -1.33%, in the last five days TRIB remained trading in the red while hitting it’s week-highest on Thursday, 11/21/24 when the stock touched $1.12 price level, adding 15.15% to its value on the day. Trinity Biotech Plc ADR’s shares saw a change of -48.02% in year-to-date performance and have moved -14.23% in past 5-day. Trinity Biotech Plc ADR (NASDAQ:TRIB) showed a performance of -44.80% in past 30-days. Number of shares sold short was 94129.0 shares which calculate 0.43 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Trinity Biotech Plc ADR (TRIB) estimates and forecasts
Statistics highlight that Trinity Biotech Plc ADR is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -32.83% of value to its shares in past 6 months, showing an annual growth rate of 48.37% while that of industry is 11.50. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 9.44% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 16.5M for the same. And 1 analysts are in estimates of company making revenue of 16M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 9.90% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 63.87% while estimates for its earnings growth in next 5 years are of 15.00%.
